On Sept. 12, President Joe Biden encouraged the nation to rally around a common goal: turning cancer from a death sen…
Last month, the UW Medicine transplant team completed the region’s first successful heart transplant from a donation-…
In a recently released study from UW researchers, new data shows that heat-related deaths are a rising issue in Washi…
Researchers at UW Medicine have announced that a study of a new monkeypox drug, tecovirimat, is looking for around 50…
Newly published research from UW School of Medicine biologists point to machine learning as having the potential to a…
A recently released study from the Journal of the American Medical Association (JAMA), Oncology led by UW’s Dr. Maris…
Nearly a month after the Supreme Court overturned Roe v. Wade, focus around the nation has turned to what the future …
Almost 200 undergraduate and graduate students presented their capstone projects at the iSchool’s first hybrid event …
Over the past several months, UW Medicine has administered over 20,000 bivalent boosters. Bivalent boosters are an updated COVID-19 vaccination including strains of both the original virus and the omicron variant to better protect against infection.
Trigger warning: Mentions of suicidal ideation.
On Oct. 31, UW announced that the COVID-19 vaccination requirement will stay in effect for students and university personnel. As of Nov. 1, on-site suppliers, vendors, contractors, and volunteers are “strongly encouraged” to have the vaccine but are no longer required to have them.
As of Sept. 2, the latest COVID-19 bivalent booster became available from Pfizer-BioNTech and Moderna. The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have both approved the booster for most of the general public.
October marks the unofficial beginning of flu season. As students and staff come back to a fall quarter with far fewer masks than in recent UW memory, experts are predicting that the 2022-2023 flu season will be especially tough and encourage anyone to get vaccinated as early as possible.
As of July 16, the new omicron subvariant, BA.5, has become the dominant strain in the United States. A recent report from the Centers for Disease Control and Prevention shows the variant accounted for approximately 78% of ongoing COVID-19 cases across the country in the past two weeks.